- Vouliez-vous dire
- region
Résultats de la recherche - 6 results
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
and territories with data. Model outcomes were extracted from 2015 to 2030 to calculate population-weighted regional averages, which were used for countries or territories without data. Regional and ...
Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia.
instructions, it could not be excluded that it concerned a genotype 6 infection as the core region line patterns on the Versant test strip were unavailable, inconclusive or atypical. Upon sequencing, seven of ...
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
to estimate the budgetary impact of reimbursement of direct-acting antivirals (DAA s). In Belgium, the restricted reimbursement criteria are mainly guided by regional seroprevalence estimates of 0.87% ...
Distribution of HCV genotypes in Belgium from 2008 to 2015.
possible impact of migration from endemic regions and prior to the increasing use of highly potent direct-acting antiviral (DAA) agents. Health Topics: Hepatitis A, B, C, D en E Hepatitis A, B, C, D and ...
Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.
reactivity of mAb A6 to full-length HCV E1E2 of genotypes 1a, 1b and 2a. Epitope mapping identified a region spanning amino acids 230-239 within the N-terminal region of E1 as critical for binding. Antibody ...
Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.
trends in birth cohort-specific HEV seroprevalence and regional differences in Belgium. HEV IgG seroprevalence was analysed on national serum banks (1579 and 2087 samples for 2006 and 2014, respectively. ...